Prospective observational study of Japanese melanoma patients treated with combination therapy using nivolumab and ipilimiumab
Not Applicable
- Conditions
- Melanoma, advanced
- Registration Number
- JPRN-UMIN000031736
- Lead Sponsor
- niversity of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Prior treatment with immune checkpoint inhibitors
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Best overall response, overall surviva, adverse events
- Secondary Outcome Measures
Name Time Method